Taiwan
· Delayed Price · Currency is TWD Senhwa Biosciences Statistics
Total Valuation
TPEX:6492 has a market cap or net worth of TWD 2.84 billion. The enterprise value is 1.83 billion.
| Market Cap | 2.84B |
| Enterprise Value | 1.83B |
Important Dates
The next estimated earnings date is Monday, May 12, 2025.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6492 has 89.15 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 89.15M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.04% |
| Owned by Institutions (%) | 0.17% |
| Float | 68.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2,843.75 |
| PB Ratio | 2.77 |
| P/TBV Ratio | 2.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.24 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.19 |
Financial Position
The company has a current ratio of 33.29, with a Debt / Equity ratio of 0.01.
| Current Ratio | 33.29 |
| Quick Ratio | 33.01 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | -461.83 |
Financial Efficiency
Return on equity (ROE) is -25.06% and return on invested capital (ROIC) is -16.16%.
| Return on Equity (ROE) | -25.06% |
| Return on Assets (ROA) | -15.76% |
| Return on Invested Capital (ROIC) | -16.16% |
| Return on Capital Employed (ROCE) | -29.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.91% in the last 52 weeks. The beta is 1.04, so TPEX:6492's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -20.91% |
| 50-Day Moving Average | 40.41 |
| 200-Day Moving Average | 46.02 |
| Relative Strength Index (RSI) | 33.80 |
| Average Volume (20 Days) | 221,648 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6492 had revenue of TWD 1.00 million and -293.75 million in losses. Loss per share was -3.29.
| Revenue | 1.00M |
| Gross Profit | 477,000 |
| Operating Income | -306.19M |
| Pretax Income | -292.46M |
| Net Income | -293.75M |
| EBITDA | -303.94M |
| EBIT | -306.19M |
| Loss Per Share | -3.29 |
Balance Sheet
The company has 1.03 billion in cash and 15.00 million in debt, giving a net cash position of 1.01 billion or 11.34 per share.
| Cash & Cash Equivalents | 1.03B |
| Total Debt | 15.00M |
| Net Cash | 1.01B |
| Net Cash Per Share | 11.34 |
| Equity (Book Value) | 1.03B |
| Book Value Per Share | 11.52 |
| Working Capital | 1.00B |
Cash Flow
In the last 12 months, operating cash flow was -294.22 million and capital expenditures -1.95 million, giving a free cash flow of -296.17 million.
| Operating Cash Flow | -294.22M |
| Capital Expenditures | -1.95M |
| Free Cash Flow | -296.17M |
| FCF Per Share | -3.32 |
Margins
| Gross Margin | 47.70% |
| Operating Margin | -30,619.10% |
| Pretax Margin | -29,246.40% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6492 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -10.33% |
| FCF Yield | -10.41% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6492 has an Altman Z-Score of 63.73.
| Altman Z-Score | 63.73 |
| Piotroski F-Score | n/a |